Cyclin E2 is the predominant E-cyclin associated with NPAT in breast cancer cells

Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells

(2013) C. Elizabeth Caldon et al.   CELL CYCLE

Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1

(2013) C. Elizabeth Caldon et al.   CELL CYCLE

Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells

(2012) C. E. Caldon et al.   MOLECULAR CANCER THERAPEUTICS

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients

(2012) MyLinh T. Duong et al.   PLoS Genetics

Lsm1 promotes genomic stability by controlling histone mRNA decay

(2011) Ana B Herrero et al.   EMBO JOURNAL

Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer

(2010) C Caldon et al.   Cell Division

Greatwall maintains mitosis through regulation of PP2A

(2009) Suzanne Vigneron et al.   EMBO JOURNAL

Aberrant Cell Cycle Progression and Endoreplication in Regenerating Livers of Mice That Lack a Single E-Type Cyclin

(2009) Yulia A. Nevzorova et al.   GASTROENTEROLOGY

The subnuclear organization of histone gene regulatory proteins and 3′ end processing factors of normal somatic and embryonic stem cells is compromised in selected human cancer cell types

(2009) Prachi N. Ghule et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Estrogen Regulation of Cyclin E2 Requires Cyclin D1 but Not c-Myc

(2009) C. E. Caldon et al.   MOLECULAR AND CELLULAR BIOLOGY